New blood test could predict arthritis risk early

Testing for antibodies that target citrullinated tenascin-C (cTNC) could diagnose rheumatoid arthritis in around 50 percent of cases, including some cases not identified by current best tests. It also has a very low rate of false positives — 98 percent accurate at ruling out rheumatoid arthritis.
Visit the Source Site

Powered by WPeMatico

New blood test could predict arthritis risk early

Testing for antibodies that target citrullinated tenascin-C (cTNC) could diagnose rheumatoid arthritis in around 50 percent of cases, including some cases not identified by current best tests. It also has a very low rate of false positives — 98 percent accurate at ruling out rheumatoid arthritis.
Visit the Source Site

Powered by WPeMatico

Sexual dysfunction: Overdiagnosed or undertreated?

The difference between mild sexual difficulties and clinically diagnosable sexual dysfunction is not a new source of debate among health professionals, but it has been stirred up recently by changes to official diagnostic criteria. A new study estimates the likely impact of these morbidity criteria on the prevalence of sexual dysfunction.
Visit the Source Site

Powered by WPeMatico